Healthcare provider profile · identity verified

Nessreen Sobh Rizvi, M.D.

Internal Medicine · BELLEVILLE, MI · NPI 1275718793

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	396	109
Levothyroxine Sodium	Levothyroxine Sodium	355	95
Atorvastatin Calcium	Atorvastatin Calcium	329	93
Amlodipine Besylate	Amlodipine Besylate	293	85
Omeprazole	Omeprazole	270	93
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	212	35
Alprazolam	Alprazolam	210	67
Rosuvastatin Calcium	Rosuvastatin Calcium	210	63
Lisinopril	Lisinopril	207	72
Metoprolol Succinate	Metoprolol Succinate	202	54
Metformin Hcl	Metformin Hcl	190	50
Famotidine	Famotidine	172	53
Simvastatin	Simvastatin	169	49
Sertraline Hcl	Sertraline Hcl	167	48
Gabapentin	Gabapentin	151	50
Hydrochlorothiazide	Hydrochlorothiazide	122	39
Eliquis	Apixaban	117	34
Atenolol	Atenolol	111	29
Trazodone Hcl	Trazodone Hcl	106	37
Potassium Chloride	Potassium Chloride	103	35
Spironolactone	Spironolactone	103	31
Meloxicam	Meloxicam	102	45
Furosemide	Furosemide	95	34
Metoprolol Tartrate	Metoprolol Tartrate	92	24
Pravastatin Sodium	Pravastatin Sodium	91	21
Fluticasone Propionate	Fluticasone Propionate	89	38
Metformin Hcl Er	Metformin Hcl	76	26
Nifedipine Er	Nifedipine	70	18
Escitalopram Oxalate	Escitalopram Oxalate	67	20
Tamsulosin Hcl	Tamsulosin Hcl	64	19
Jardiance	Empagliflozin	63	17
Zolpidem Tartrate	Zolpidem Tartrate	61	29
Glimepiride	Glimepiride	60	11
Tramadol Hcl	Tramadol Hcl	59	26
Ozempic	Semaglutide	58	15
Methocarbamol	Methocarbamol	57	26
Allopurinol	Allopurinol	56	12
Carvedilol	Carvedilol	56	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	56	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	14
Tizanidine Hcl	Tizanidine Hcl	52	22
Acetaminophen-Codeine	Acetaminophen With Codeine	50	12
Donepezil Hcl	Donepezil Hcl	50	11
Hydralazine Hcl	Hydralazine Hcl	50	15
Azelastine Hcl	Azelastine Hcl	48	22
Montelukast Sodium	Montelukast Sodium	48	11
Azithromycin	Azithromycin	47	37
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	18
Pantoprazole Sodium	Pantoprazole Sodium	44	15
Albuterol Sulfate Hfa	Albuterol Sulfate	43	27
Prednisone	Prednisone	42	33
Bupropion Xl	Bupropion Hcl	41	15
Lorazepam	Lorazepam	41	11
Nystatin	Nystatin	41	11
Ventolin Hfa	Albuterol Sulfate	39	18
Ibuprofen	Ibuprofen	37	19
Synthroid	Levothyroxine Sodium	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	30	30
Enalapril Maleate	Enalapril Maleate	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	14
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	11
Ipratropium Bromide	Ipratropium Bromide	29	13
Clonazepam	Clonazepam	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	14
Estradiol	Estradiol	28	11
Ezetimibe	Ezetimibe	28	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	26	26
Meclizine Hcl	Meclizine Hcl	26	12
Alfuzosin Hcl Er	Alfuzosin Hcl	25	suppressed
Glipizide	Glipizide	25	suppressed
Amoxicillin	Amoxicillin	24	17
Hydroxyzine Hcl	Hydroxyzine Hcl	24	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	20
Chlorthalidone	Chlorthalidone	23	suppressed
Fluconazole	Fluconazole	23	15
Tolterodine Tartrate Er	Tolterodine Tartrate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	17
Hydrocortisone	Hydrocortisone	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Methylprednisolone	Methylprednisolone	21	16
Diazepam	Diazepam	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Risedronate Sodium	Risedronate Sodium	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Topiramate	Topiramate	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Lactulose	Lactulose	16	suppressed
Felodipine Er	Felodipine	15	suppressed
Finasteride	Finasteride	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	13
Xarelto	Rivaroxaban	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Temazepam	Temazepam	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error